Ignite Creation Date:
2024-05-06 @ 3:30 PM
Last Modification Date:
2024-10-26 @ 1:50 PM
Study NCT ID:
NCT04653246
Status:
RECRUITING
Last Update Posted:
2024-06-03
First Post:
2020-11-27
Brief Title:
Isatuximab Lenalidomide Bortezomib and Dexamethasone in NDMM
Sponsor:
Jacob Laubach MD
Organization:
Dana-Farber Cancer Institute
Organization Data
Organization:
Dana-Farber Cancer Institute
Class:
OTHER
Study ID:
20-207
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Jacob Laubach MD
Lead Sponsor Class:
OTHER
Responsible Party:
Jacob Laubach MD
Responsible Party Title:
Sponsor Investigator
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Dana-Farber Cancer Institute
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Sanofi | INDUSTRY |